DNA – Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. It operates through two segments: Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It offers Concentric, which is a global infrastructure for biosecurity to prevent, detect and respond to a wide variety of biological threats. The Company is also engaged in building and deploying machine learning models to solve impactful problems in biology.